Development of nanoemulsion-based in situ gel formulation of escitalopram oxalate for intranasal delivery in depression therapy
The optimized nanoemulsion-based in situ gel demonstrated sustained drug release, enhanced nasal permeation, acceptable safety, and improved antidepressant efficacy and Pharmacodynamic evaluation showed significantly greater reduction in depressive-like behaviours than oral escitalopram solution.